MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
AKTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Akari Therapeutics (AKTX) Ownership - Who owns Akari Therapeutics?

Akari Therapeutics PLC is an oncology company developing next-generation antibody-drug conjugates (ADCs) built around novel, proprietary payloads utilizing powerful biology to attack cancer... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Pharmaceuticals Major
Address
401 East Jackson Street
Phone
+1 929 274-7510
Employees
6
Web
https://www.akaritx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
16.99M
P/E Ratio
N/A
Total Cash
2.48M
Projected Growth
N/A
Total Debt
2.12M
Revenue
N/A
Risk (Beta)
0.18
Dividend Yield
N/A
Total Cash/Share
2.17
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
AKTX
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for AKTX
A.I. Advisor
published General Information

General Information

a developer of biopharmaceuticals

Industry Biotechnology

Profile
Details
Industry
Pharmaceuticals Major
Address
401 East Jackson Street
Phone
+1 929 274-7510
Employees
6
Web
https://www.akaritx.com